The MedTech industry is accelerating at an unprecedented pace. As AI reshapes the landscape, global collaborations are expanding, and the regulatory frameworks are evolving to meet new challenges.

Med-tech M&A activity cooled in 2025, with total reported deal value falling to about $42.14 billion, down from $57.9 billion in 2024 and far below the levels seen in 2021 and 2022, when annual totals ...

Abbott made one of the biggest deals in recent medtech history last week when it announced its plan to acquire Exact Sciences — maker of colon cancer screening test Cologuard — for $23 billion.

Full-year 2025 operational sales growth is projected at 3.3%-4.3%, with a midpoint of $92 billion. This includes contributions from the Intra-Cellular acquisition ...